ACTRN12619000390189招募中未知
Exploring changes in tear film stability and dry eye symptoms following 6 months Systane® artificial tear supplement application for dry eye disease (DED)
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 84
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •Able and willing to comply with study instructions
- •Minimum of 6 months since onset of self-reported DED
- •Normal lid architecture, and eyelid closure
- •Dry eye diagnosis according to the TFOS DEWS II diagnostic criteria (Symptoms: DEQ5 or OSDI and Signs: at least 1 positive finding on NIKBUT/osmolarity/staining).
排除标准
- •Non-normal lid architecture affecting lid closure/blink
- •Inability or refusal to commit to 6-month trial
- •Refusal or inability to refrain from topical eye drop use, including artificial tear supplements, for at least 48 hours prior to baseline visit
- •Refusal to restrict topical eye drop use to only the study tear supplement
- •Refusal to be advised of incidental findings
- •Wear of contact lenses within 48 hours of study commencement or during the study
- •Warm compress therapy, unless performed regularly, for a minimum of 30 days, and maintained at the same frequency throughout the course of the trial
- •Punctal plugs, unless non-dissolvable (silicone plugs or cautery of at least 3 months duration)
- •History of ocular surgery (such as refractive or cataract surgery) in either eye within 3 months of the screening visit
- •History or presence of any ocular disorder or condition in either eye that would likely interfere with the interpretation of the study results or patient safety. This includes but is not limited to significantly reduced visual acuity (less than 20/200), significant corneal or conjunctival scarring, pterygium or nodular pinguecula; current ocular infection or inflammation unrelated to dry eye; anterior (epithelial) basement membrane corneal dystrophy or other clinically significant corneal dystrophy or degeneration; ocular herpetic infection
- •Use of topical medications that might interfere with the study outcomes, or deemed to be contraindicated for participation
- •A systemic condition or disease considered unstable or judged by the investigator to be incompatible with participation in the study (including but not limited to current systemic infection, uncontrolled autoimmune disease, uncontrolled immunodeficiency disease, history of myocardial infarction)
- •Self-reported pregnancy or lactation
- •Active or uncontrolled severe systemic allergy, chronic seasonal allergies, rhinitis or sinusitis requiring treatment (with antihistamines, decongestants, oral or aerosol steroids) at the time of screening
- •Use of medication known to cause ocular drying (including but not limited to antihistamines, tricyclic antidepressants, anxiolytics, antimuscarinics, beta-blocking agents, diuretics, phenothiazines, steroids) within 30 days of the screening visit
- •Use of oral medications not associated with ocular drying, unless stable dose for at least 3 months and continued at the same dose throughout trial
- •Participation in any clinical trial with a new active substance or a new device within 30 days of the screening visit
研究者
相似试验
已完成
不适用
Changes in tear film stability on the ocular surface when wearing facemasknormal, dry eyeJPRN-UMIN000045398Toho university omori medical center60
已完成
不适用
The effect of Optimel Manuka+ Dry Eye Drops with adjunctive treatment on signs and symptoms of dry eyeDry eye diseaseEye - Diseases / disorders of the eyeACTRN12621000336886SW Sydney34
招募中
Unknown
Changes in ocular surface after instillation of eye drops containing PVPHealthy wearers. It is expected to find ways to reduce contact lens discomfort.JPRN-jRCT1031230239Hori Yuichi26
尚未招募
Unknown
Effect of lipid loaded daily disposable contact lenses on tear film break upcontact lens related discomfortEye - Diseases / disorders of the eyeACTRN12624000744550niversity of New South Wales10
招募中
不适用
To study the correlation of tearfilm and intraocular inflammatory mediators with outcome of glaucoma surgery in human eyesCTRI/2018/05/014280Postgraduate Institute of Medical Education and Research